Best Practices and Advances in Treatment Strategies in Bipolar Disorder Pharmacotherapy (ACPE)

Bipolar disorder is a mood disorder characterized by episodes of mania, hypomania, and depression. It affects 3-4% of the U.S. population, represents a substantial societal and economic burden in the United States, is also found to be strongly associated with other major public health concerns like diabetes and cardiovascular disease as well as suicide.

The literature demonstrates that medication nonadherence is a major issue among patients with bipolar disorder. Nonadherence affects approximately 60% of patients and can result in hospitalization, poor effectiveness, increased relapses, and increased risk of morbidity. Other factors, such as patient perceptions, illness severity, and the relationship between the physician and patient, come into play and should be taken into account to optimize adherence.

Objectives

1. Describe the pathophysiology of bipolar disorder and the role the neurotransmitters play in them
2. Describe the benefits and risks of pharmacotherapy for patients presenting with bipolar disorder and take them into account when formulating treatment plans for patients.
3. Recommend therapy changes in patients with bipolar disorder who are unable to tolerate a prescribed treatment
4. Identify barriers to care in patients with bipolar disorder and develop strategies to abate them

Credit Designation:

ScientiaCME is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmaceutical education. This program is approved for 0.75 hours of continuing education. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.